- Home
- DRVN vs KNSA Comparison
DRVN vs KNSA Comparison
Compare DRVN & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRVN | KNSA |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.4B |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DRVN | KNSA |
|---|---|---|
| Price | $10.53 | $46.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $19.57 | ★ $55.29 |
| AVG Volume (30 Days) | ★ 2.2M | 574.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 59.82 | ★ 225.00 |
| EPS | 0.69 | ★ 0.75 |
| Revenue | ★ $2,339,588,000.00 | $677,564,000.00 |
| Revenue This Year | N/A | $38.01 |
| Revenue Next Year | $2.10 | $17.42 |
| P/E Ratio | ★ $15.28 | $61.77 |
| Revenue Growth | 1.54 | ★ 60.09 |
| 52 Week Low | $9.80 | $18.26 |
| 52 Week High | $19.74 | $49.12 |
Technical Indicators
Market Signals| Indicator | DRVN | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 22.34 | 55.14 |
| Support Level | $9.80 | $40.47 |
| Resistance Level | $15.91 | $46.48 |
| Average True Range (ATR) | 0.59 | 2.16 |
| MACD | -0.25 | 0.00 |
| Stochastic Oscillator | 10.44 | 64.75 |
Price Performance
Historical ComparisonAbout DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.